ITRM20070394A1 - Liposomi asimmetrici e loro usi in campo medico. - Google Patents

Liposomi asimmetrici e loro usi in campo medico.

Info

Publication number
ITRM20070394A1
ITRM20070394A1 IT000394A ITRM20070394A ITRM20070394A1 IT RM20070394 A1 ITRM20070394 A1 IT RM20070394A1 IT 000394 A IT000394 A IT 000394A IT RM20070394 A ITRM20070394 A IT RM20070394A IT RM20070394 A1 ITRM20070394 A1 IT RM20070394A1
Authority
IT
Italy
Prior art keywords
liposomas
asymmetric
medical field
medical
field
Prior art date
Application number
IT000394A
Other languages
English (en)
Inventor
Spirito Marco De
Maurizio Fraziano
Emanuela Greco
Gianluca Quintiliani
Original Assignee
Uni Cattolica Del Sacro Cuo Re
Uni Degli Studi Di Roma To R V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Cattolica Del Sacro Cuo Re, Uni Degli Studi Di Roma To R V filed Critical Uni Cattolica Del Sacro Cuo Re
Priority to IT000394A priority Critical patent/ITRM20070394A1/it
Priority to PCT/IT2008/000474 priority patent/WO2009011007A2/en
Priority to AU2008277235A priority patent/AU2008277235A1/en
Priority to MX2010000471A priority patent/MX2010000471A/es
Priority to EP08790061A priority patent/EP2178602A2/en
Priority to US12/667,257 priority patent/US20100178330A1/en
Publication of ITRM20070394A1 publication Critical patent/ITRM20070394A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT000394A 2007-07-16 2007-07-16 Liposomi asimmetrici e loro usi in campo medico. ITRM20070394A1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT000394A ITRM20070394A1 (it) 2007-07-16 2007-07-16 Liposomi asimmetrici e loro usi in campo medico.
PCT/IT2008/000474 WO2009011007A2 (en) 2007-07-16 2008-07-15 Asymmetric liposomes and uses in medical field thereof
AU2008277235A AU2008277235A1 (en) 2007-07-16 2008-07-15 Asymmetric liposomes and uses in medical field thereof
MX2010000471A MX2010000471A (es) 2007-07-16 2008-07-15 Liposomas asimetricas y usos de las mismas en el campo medico.
EP08790061A EP2178602A2 (en) 2007-07-16 2008-07-15 Asymmetric liposomes and uses in medical field thereof
US12/667,257 US20100178330A1 (en) 2007-07-16 2008-07-15 Asymmetric liposomes and uses in medical field thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000394A ITRM20070394A1 (it) 2007-07-16 2007-07-16 Liposomi asimmetrici e loro usi in campo medico.

Publications (1)

Publication Number Publication Date
ITRM20070394A1 true ITRM20070394A1 (it) 2009-01-17

Family

ID=40260195

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000394A ITRM20070394A1 (it) 2007-07-16 2007-07-16 Liposomi asimmetrici e loro usi in campo medico.

Country Status (6)

Country Link
US (1) US20100178330A1 (it)
EP (1) EP2178602A2 (it)
AU (1) AU2008277235A1 (it)
IT (1) ITRM20070394A1 (it)
MX (1) MX2010000471A (it)
WO (1) WO2009011007A2 (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009118658A2 (en) * 2008-03-26 2009-10-01 University Of Oxford Endoplasmic reticulum targeting liposomes
CA2757026A1 (en) 2009-03-27 2010-09-30 The Chancellor, Masters And Scholars Of The University Of Oxford Cholesterol level lowering liposomes
EP2906570A4 (en) * 2012-10-15 2016-06-08 Yeda Res & Dev USE OF LONG-TERM SPHINGOID BASES AND THEIR ANALOGUE IN THE TREATMENT AND PREVENTION OF BACTERIAL INFECTIONS
US20180153807A1 (en) * 2015-04-22 2018-06-07 Matinas Biopharma Nanotechnologies, Inc. Compositions and methods for treating mycobacteria infections and lung disease
IL260690A (en) 2018-07-19 2018-12-31 Yeda Res & Dev Sphingosine derivatives and their use against pulmonary bacterial infections
WO2024028741A1 (en) * 2022-08-02 2024-02-08 Biolt S.R.L.S. Liposome comprising phosphatidylserine, phosphatidic acid and optionally cholesterol, composition and medical use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH624011A5 (it) * 1977-08-05 1981-07-15 Battelle Memorial Institute
US5204112A (en) * 1986-06-16 1993-04-20 The Liposome Company, Inc. Induction of asymmetry in vesicles
US5252263A (en) * 1986-06-16 1993-10-12 The Liposome Company, Inc. Induction of asymmetry in vesicles
CA2319928A1 (en) * 2000-09-18 2002-03-18 Vasogen Ireland Limited Apoptosis-mimicking synthetic entities and use thereof in medical treatments
DE60218872T2 (de) * 2001-09-18 2007-12-20 Vasogen Ireland Ltd., Shannon Verwendung von synthetischen oder natürlichen apoptose-vortäuschenden einheiten zur beschleunigten erholung von verletzungen

Also Published As

Publication number Publication date
WO2009011007A2 (en) 2009-01-22
MX2010000471A (es) 2010-06-02
WO2009011007A3 (en) 2009-03-19
US20100178330A1 (en) 2010-07-15
AU2008277235A1 (en) 2009-01-22
EP2178602A2 (en) 2010-04-28

Similar Documents

Publication Publication Date Title
BRPI0921919A2 (pt) dispositivos médicos, aparelhos, sistemas e métodos
BRPI0915299A2 (pt) poliamida, composição compreendendo tal poliamida e utilização das mesmas
BRPI0821276A2 (pt) Produto, e, uso do produto
BRPI0820379A2 (pt) Sistemas e métodos de dispensação de produto médico
BRPI0718182A2 (pt) Oligorribonucleotídeos e seus usos.
BRPI0908864A2 (pt) formas da rifaximina e usos das mesmas
BRPI0815773A2 (pt) composto, e, medicamento.
BRPI0910925A2 (pt) conjuntos de transferência de líquido e métodos relacionados
BRPI0812264A2 (pt) Vesícula, e, preparação externa para pele
BRPI1010549A2 (pt) dispositivo de campo, e, fluxímetro magnético.
ITMI20080027A1 (it) Combinazione biocida per impiego in campo agricolo
DK2235002T3 (da) 4-pyridinonforbindelser og anvendelse heraf til behandling af cancer
BR112012007861A2 (pt) dispositivos médicos e suas bombas
BRPI0913175A2 (pt) artigo antibalístico, e, uso do mesmo.
BRPI0818641A2 (pt) Rótulo, e, uso do rótulo
DK2276760T3 (da) Kondenserede ringforbindelser og anvendelse deraf
IT1399793B1 (it) Procedimento di preparazione di una biomassa comprendente plantaricina e suoi usi in campo medico.
ITRM20070394A1 (it) Liposomi asimmetrici e loro usi in campo medico.
DK2310383T3 (da) 2-oxo-alkyl-1-piperazin-2-onderivater, fremstilling deraf og terapeutisk anvendelse deraf
IT1398768B1 (it) Uso di microrna-199b-5p in campo medico e diagnostico.
IT1399130B1 (it) Derivati indolici e loro uso in campo medico.
BRPI0813187A2 (pt) 13-hidroperóxido liases modificadas e respectivos usos.
ITRM20070582A1 (it) Composizione farmaceutica comprendente olio e colesterolo perossidati e suoi usi in campo medico.
BR112012025829A2 (pt) ''composição de tratamento, composição líquido e utilização''
BRPI0920661A2 (pt) elemento protetor, e, utilização do mesmo